Non-Immunoglobulin E-mediated Food Allergies in Children

计划入组 150 人 · 首次发布于 2020 年 7 月 8 日

A 52-week Study of Remibrutinib in IgE-mediated Food Allergy

计划入组 576 人 · 首次发布于 2026 年 8 月 17 日

Phase 2b Study of RPT904 as Monotherapy in Participants With IgE-Mediated Food Allergy

计划入组 100 人 · 首次发布于 2025 年 10 月 24 日

IgE inhibitors (oral, allergy/asthma)

food-ASIT+

DPX-based vaccines (food allergies/ peanut allergy)

Allergy Laboratories, Inc.

United States

Halton Pediatric Allergy

Canada

HAL Allergy BV

Netherlands

Dupilumab Shows Promise in Reducing IgE Levels in Food Allergy Patients

Omalizumab Approval and Media Impact Highlight Top Food Allergy Stories of 2024

DBV Technologies Advances Viaskin Peanut Patch with FDA and EMA Support